Cover Technologies Inc Share Price Canadian Securities Exchange
Equities
HAVN
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 CAD | -13.46% | -26.76% | +52.94% |
Sales 2021 | - | Sales 2022 | 0.28 0.38 23.07 | Capitalization | 10.7M 14.61M 893M |
---|---|---|---|---|---|
Net income 2021 | -30M -40.98M -2.5B | Net income 2022 | -22M -30.05M -1.84B | EV / Sales 2021 | - |
Net cash position 2021 | 8.95M 12.22M 746M | Net cash position 2022 | 666K 910K 55.6M | EV / Sales 2022 | 3,62,79,535 x |
P/E ratio 2021 |
-1.38
x | P/E ratio 2022 |
-0.4
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.5% |
1 day | -13.46% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 06/20/06 |
Jenna Pozar
COO | Chief Operating Officer | - | 01/21/01 |
Director/Board Member | - | 04/20/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 06/20/06 |
Ivan Casselman
BRD | Director/Board Member | - | - |
Director/Board Member | - | 04/20/04 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- HAVN Stock
- HAVN Stock